Accelerated approval: FDA explains when it considers confirmatory trials underway
Regulatory NewsFerdous Al-Faruque
Approval/marketing authorizationClinical TrialsComplianceGuidancePharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited States